Clinical implications of using both fluoropyrimidine and paclitaxel in patients with severe peritoneal metastasis of gastric cancer: A post hoc study of JCOG1108/WJOG7312G

BACKGROUND: In the JCOG1108/WJOG7312G trial, a combination (FLTAX) of 5‐fluorouracil (FU) /leucovorin (FL) and paclitaxel (PTX) did not show superiority in overall survival (OS) to FL in untreated patients with severe peritoneal metastasis of gastric cancer (GC‐SPM), some of whom received second‐lin...

Descripción completa

Detalles Bibliográficos
Autores principales: Arai, Hiroyuki, Inoue, Eisuke, Yamaguchi, Kensei, Boku, Narikazu, Hara, Hiroki, Nishina, Tomohiro, Tsuda, Masahiro, Shitara, Kohei, Shinozaki, Katsunori, Nakamura, Shinichiro, Hyodo, Ichinosuke, Muro, Kei, Sasako, Mitsuru, Terashima, Masanori, Nakajima, Takako E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559492/
https://www.ncbi.nlm.nih.gov/pubmed/34655175
http://dx.doi.org/10.1002/cam4.4303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559492/
https://www.ncbi.nlm.nih.gov/pubmed/34655175
http://dx.doi.org/10.1002/cam4.4303

Ejemplares similares